H., Solari F
Popular weight loss drugs tied to hair loss in study People taking popular GLP-1 medications such as Ozempic, Wegovy and Mounjaro may face a higher risk of hair loss than patients using other diabetes drugs, according to a new study published in The British Medical Journal
At LifeRx.md, we guide patients to track progress beyond the mirror
GLP-1 medications are among the latest advancements in diabetes and weight loss management, and include medications like Ozempic, Wegovy, Trulicity, and Mounjaro
At the 3 month mark, the treatment group averaged between 6% and 8% reduction in body weight
Healthcare providers are advised to inform patients about the potential risk of thyroid tumors when prescribing tirzepatide and to counsel them on symptoms that might suggest thyroid cancer, including a neck mass, dysphagia, dyspnea, or persistent hoarseness